HTA and health technology assessment
Accelerate the adoption of health innovations.
Methodological and strategic support to prepare clear, credible HTA dossiers aligned with reviewer expectations.
Structure clinical, economic, and budget evidence to respond clearly to reviewer expectations.
Preparing a dossier that answers real decision questions
An HTA dossier should not merely accumulate evidence. It should answer the questions that shape the decision: medical need, relevant comparator, clinical value, economic value, uncertainty, budget impact, and adoption feasibility.
Santicxis helps organize these dimensions to produce a clearer, stronger dossier that is more useful in discussions with reviewers.
Making uncertainty discussable
HTA decisions are often made with incomplete evidence, especially for innovations, rare diseases, or specific populations. The challenge is not to hide uncertainty, but to make it explicit, test it, and show how it can be managed.
This transparency strengthens the credibility of the dossier and better prepares institutional exchanges.